
Lumos Diagnostics continues to expand its commercial footprint through FDA clearance, growing U.S. adoption, manufacturing partnerships, and paediatric research. The company now focuses on turning regulatory success and market access into recurring sales, broader reimbursement, and sustainable long-term growth.

Invictus Energy is progressing its Cabora Bassa gas project in Zimbabwe, with Mukuyu appraisal and Musuma-1 drilling as key catalysts. While the PPSA reduces regulatory risk, IVZ remains a volatile, pre-revenue explorer reliant on external funding.
.webp&w=828&q=75)
Vulcan Energy Resources (ASX: VUL) advances its Zero Carbon Lithium project with progressing development, strategic partnerships, and strengthened funding pathways, positioning the company as a unique European lithium supplier amid rising demand for decarbonised battery materials.
.webp&w=828&q=75)
Aeris Resources (ASX: AIS) delivers solid FY26 production, strong cash generation, and transformational growth via South Cobar acquisition, positioning for sustained copper‑gold expansion into FY27.
.webp&w=828&q=75)
Liontown is transitioning from development to production as Kathleen Valley ramps up. While operational progress continues, weakness in the lithium market and technical selling have weighed sentiment, making execution, costs, and expansion progress key factors for investors.
.webp&w=828&q=75)
Larvotto Resources enters a key operational phase as Hillgrove commissioning begins, copper expansion progresses, and the weekly chart tests important support and resistance levels while investors watch execution and future growth catalysts.
...